Yiming Xu

Executive Director, Head of Business Development @ RemeGen荣昌生物

About

I lead global business development at RemeGen, one of China's leading innovative biopharma companies, bridging innovation across borders to deliver transformative therapies to patients worldwide.My work spans the full spectrum of global licensing: identifying the right partners to maximize our assets' reach, and selectively acquiring programs that strengthen our pipeline. I focus on cross-border deal structuring, valuation, and stakeholder alignment across regulatory environments, operating at the intersection of science, strategy, and commercial execution.I stay closely connected to the global biotech ecosystem through regular international travel.

Country

China

City

Beijing

Industry

Pharmaceuticals

Skill

Experience

Executive Director, Head of Business Development

RemeGen荣昌生物

2026-4 - Present · 6 mos

北京市, 中国

I lead RemeGen’s global licensing efforts, spanning both out- and in-licensing, from opportunity identification through deal execution and closure. Recent Transactions (2025): Out-Licensing to Top-5 Global Pharma: Led negotiation of a $5.6B biobucks deal ($650M upfront). This transaction established RemeGen as a credible partner in the global oncology space and validated our innovation capabilities with top-tier pharmaceutical companies. Ophthalmology Asset Out-Licensing: Closed a $200M deal with a leading specialty pharma for Asian market rights, identifying and securing the right regional partner to maximize value for this differentiated asset.